Title : EURORDIS - The Voice of Rare Disease Patients in Europe
link : EURORDIS - The Voice of Rare Disease Patients in Europe
EURORDIS - The Voice of Rare Disease Patients in Europe
EURORDIS - The Voice of Rare Disease Patients in Europe
The Voice of Rare Disease
Patients in Europe
Breaking the Access Deadlock to Leave No One Behind
A contribution by EURORDIS and its members on possibilities for patients' full and equitable access to rare disease therapies in Europe
This position paper is a contribution from EURORDIS and its members that offers a synthesis of their analysis, reflections and perspectives on the issue of access to rare disease therapies.
The position paper sets out a new four-pillar approach to tackling the challenges that prevent patients’ access to care and medicines, as well as the ambition to have 3 to 5 times more new rare disease therapies approved per year by 2025, 3 to 5 times cheaper than today.
In the paper, EURORDIS calls for a new model based on a collective conversation involving all stakeholders (patients, the pharmaceutical industry, national competent authorities, national health ministries, researchers, scientists and the European Medicines Agency).
Thus Article EURORDIS - The Voice of Rare Disease Patients in Europe
That's an article EURORDIS - The Voice of Rare Disease Patients in Europe This time, hopefully can give benefits to all of you. well, see you in posting other articles.
You are now reading the article EURORDIS - The Voice of Rare Disease Patients in Europe with the link address https://coneknews.blogspot.com/2018/01/eurordis-voice-of-rare-disease-patients_19.html
0 Response to "EURORDIS - The Voice of Rare Disease Patients in Europe"
Post a Comment